A two-day workshop organised by the AACB/RCPAQAP Toxicology and Therapeutic Drugs Advisory Committees.

The AACB/RCPAQAP Toxicology and Therapeutic Drugs Advisory Committees have organised back-to-back in-person workshops at the RCPAQAP facility with expert speakers designed to inform clinical laboratories that offer toxicology and TDM services about current and emerging challenges.

Method development, updates to accreditation requirements, new and emerging therapeutic drugs and challenges in staying current in the ever-changing drugs of abuse landscape.

Target audience:
Pathologists, Scientists, Researchers and other health professionals

Expected outcomes:

An understanding of the process to set-up new TDM and Toxicology assays in your laboratory
An understanding of the potential pitfalls with some immunoassay toxicology methods
The changes needed to comply with the new ISO 4023 standard
Better patient outcomes where appropriate TDM is available
How new antibiotics, Cystic Fibrosis and TB drugs are changing lives
What are the emerging drugs of abuse and how to stay current with detection and confirmation
What is the expectation when a “Drug Screen” is requested
Opportunities to interact with expert speakers
Certificate of Attendance
In-person event only

Day 1: Tue 1 Apr
8:30 – 9:00	Registration
	Welcome & Introduction - Peter Graham
	Session 1: Accreditation / EQA / QC TDM
09.00-09.30	QAP - identifying patient risk - Peter Graham + Dr Chris Farrell
09.30-10.00	Monitoring quality of TDM assays across a network - Lisa Jolly
10.00-10.30	Source of therapeutic intervals - Professor Graham Jones + Danijela Kocic
10.30–11.00	Morning tea
	Session 2: TDM in routine laboratories
11.00-11.30	Setting up a MS assay for a new therapeutic drug - Danijela Kocic
11.30-12.00	Offering a laboratory service for TB, CF and immunotherapy monitoring - Brett McWhinney
12.00-12.30	Immunosuppressant Case Studies - Betty Sallustio
12.30–1.30	Lunch
	Session 3: Emerging fields
13.30-14.00	Lessons learned: Implementation of a TDM Service - A/Professor Jane Carland
14.00-14.30	Anti-microbial drug TDM - Professor Debbie Marriott
14.30-15.00	Picking the right time point for TDM - Professor Jan-Willem Alffenaar
3.00-3.15	Afternoon Tea
	Panel Discussions: Ask the experts
15.15-16.00	Q&A - Special Drugs Advisory Committee
16.00	Meeting Close
1600-1800	Networking Drinks

Day 2: Wed 2 Apr
8:30 – 9:00	Registration
	Welcome & Introduction - Grant Moore
	Session 1: Accreditation
09.00-09.30	Standard urine drug screen - what to order? - Professor Graham Jones
09.30-10.00	Un/suitability of AS/NZS4308 for clinical/medical laboratories - Grant Moore
10.00-10.30	Insights from the Urine Toxicology EQA Program - Bernadette James
10.30–11.00	Morning tea
	Session 2: Medico-Legal challenges for the Toxicology Laboratory
11.00-11.30	Medicinal cannabis - Helen Martin
11.30-12.00	Forensic toxicology - Stacey Richards
12.00-12.30	Poppy seeds - food grade vs pharmacological - Chris Cruikshank
12.30–1.30	Lunch
	Session 3: Common analytical issues encountered in the toxicology laboratory
13.30-14.00	Immunoassay drug screens: cross-reactivity & different methodologies - Yoke Leong
14.00-14.30	Novel Benzodiazepine Detections in a Queensland Public Drug Screening Laboratory - Darren Allen
14.30-15.00	Nitazenes, Kava and synthetic cannabinoids - Tim Smith
3.00-3.15	Afternoon Tea
	Panel Discussions: Ask the experts
15.15-16.00	Q&A - Toxicology Advisory Committee
16.00	Meeting Close

Travelling to the RCPAQAP Office:

Driving: We have created a map with available parking close by. View.

Public Transport: Our closest train station is St Leonards. It is approximately 8-10 minute walk to our office.